Factor XII: form determines function

被引:62
作者
de Maat, S. [1 ]
Maas, C. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Clin Chem & Hematol, Utrecht, Netherlands
关键词
blood coagulation; bradykinin; factor XII; plasmin; prekallikrein; CONTACT SYSTEM ACTIVATION; HEREDITARY ANGIOEDEMA; TRANEXAMIC ACID; BINDING-SITE; ENHANCED SUSCEPTIBILITY; PLASMINOGEN-ACTIVATOR; VASCULAR-PERMEABILITY; THROMBUS FORMATION; BLOOD-COAGULATION; BRAIN EDEMA;
D O I
10.1111/jth.13383
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Factor XII is a mysterious plasma protein without a clear physiologic function. It was identified as a clotting factor, but has no clear role in hemostasis. However, FXII also contributes to the production of bradykinin, a short-lived inflammatory peptide. A growing body of mechanistic research from animal models indicates that FXII contributes to thrombotic disease by triggering excessive coagulation. FXII is evolutionarily conserved, suggesting that this molecule does have a physiologic function. This leads to intriguing questions: What does FXII really do? Is it even a real clotting factor at all? Before the groundbreaking discovery of a role for FXII in thrombotic disease, many studies investigated the biochemical properties of FXII and its activators. In this review, we highlight several biochemical studies that reveal much about the natural behavior of FXII. On the basis of these findings, it is possible to draft a conceptual model to explain how FXII reacts to surface materials. We then discuss how this model applies to the activities of FXII in its natural environment. There are two tentative physiologic functions of FXII that can operate exclusively: (i) maintenance of thrombus stability; (ii) local regulation of vascular permeability. Either, or both, of these natural functions may explain the evolutionary development and maintenance of FXII.
引用
收藏
页码:1498 / 1506
页数:9
相关论文
共 75 条
[1]   Prekallikrein deficiency:: The characteristic normalization of the severely prolonged aPTT following increased preincubation time is due to autoactivation of factor XII [J].
Asmis, LM ;
Sulzer, I ;
Furlan, M ;
Lämmle, B .
THROMBOSIS RESEARCH, 2002, 105 (06) :463-470
[2]   In Vitro Hemocompatibility Testing of Dyneema Purity Fibers in Blood Contact [J].
Basir, Amir ;
de Groot, Philip ;
Grundeman, Paul F. ;
Tersteeg, Claudia ;
Maas, Coen ;
Barendrecht, Arjan ;
van Herwaarden, Joost ;
Kluin, Jolanda ;
Moll, Frans ;
Pasterkamp, Gerard ;
Roest, Mark .
INNOVATIONS-TECHNOLOGY AND TECHNIQUES IN CARDIOTHORACIC AND VASCULAR SURGERY, 2015, 10 (03) :195-201
[3]   Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III [J].
Bjoerkqvist, Jenny ;
de Maat, Steven ;
Lewandrowski, Urs ;
Di Gennaro, Antonio ;
Oschatz, Chris ;
Schoenig, Kai ;
Noethen, Markus M. ;
Drouet, Christian ;
Braley, Hal ;
Nolte, Marc W. ;
Sickmann, Albert ;
Panousis, Con ;
Maas, Coen ;
Renne, Thomas .
JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (08) :3132-3146
[4]   Zinc-dependent contact system activation induces vascular leakage and hypotension in rodents [J].
Bjorkqvist, Jenny ;
Lecher, Bernd ;
Maas, Coen ;
Renne, Thomas .
BIOLOGICAL CHEMISTRY, 2013, 394 (09) :1195-1204
[5]  
BLOHME G, 1972, ACTA MED SCAND, V192, P293
[6]   ACTIVATION OF INTRINSIC BLOOD-COAGULATION BY ELLAGIC ACID - INSOLUBLE ELLAGIC ACID-METAL ION COMPLEXES ARE THE ACTIVATING SPECIES [J].
BOCK, PE ;
SRINIVASAN, KR ;
SHORE, JD .
BIOCHEMISTRY, 1981, 20 (25) :7258-7266
[7]   REFINED CRYSTAL-STRUCTURE OF BOVINE BETA-TRYPSIN AT 1.8 A RESOLUTION .2. CRYSTALLOGRAPHIC REFINEMENT, CALCIUM-BINDING SITE, BENZAMIDINE BINDING-SITE AND ACTIVE-SITE AT PH 7.0 [J].
BODE, W ;
SCHWAGER, P .
JOURNAL OF MOLECULAR BIOLOGY, 1975, 98 (04) :693-717
[8]   Characterization of a partial exon 9/intron 9 deletion in the coagulation factor XII gene (F12) detected in two Turkish families with hereditary angioedema and normal C1 inhibitor [J].
Bork, K. ;
Wulff, K. ;
Hardt, J. ;
Witzke, G. ;
Lohse, P. .
HAEMOPHILIA, 2014, 20 (05) :e372-e375
[9]   A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor [J].
Bork, Konrad ;
Wulff, Karin ;
Meinke, Peter ;
Wagner, Nicola ;
Hardt, Jochen ;
Witzke, Guenther .
CLINICAL IMMUNOLOGY, 2011, 141 (01) :31-35
[10]   Increased plasmin-α2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses [J].
Bouma, B. ;
Maas, C. ;
Hazenberg, B. P. C. ;
Lokhorst, H. M. ;
Gebbink, M. F. B. G. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (06) :1139-1142